The global market for Broad-spectrum Antibiotics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Broad-spectrum Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Broad-spectrum Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Broad-spectrum Antibiotics include Hanmi Cepha Plant, Globela Pharma, Allergan Plc, Bristol-Myers Squibb Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc, Novartis International AG, Pfizer Inc, Sanofi, and Teva Pharmaceutical Industries Ltd, NextPharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Broad-spectrum Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Broad-spectrum Antibiotics.

The Broad-spectrum Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Broad-spectrum Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Broad-spectrum Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Broad-spectrum Antibiotics Market Report

Report Metric	Details
Report Name	Broad-spectrum Antibiotics Market
Segment by Type	Cephalosporins Penicillins Carbapenems Tetracyclines Chloramphenicol Others
Segment by Application	Hospital Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hanmi Cepha Plant, Globela Pharma, Allergan Plc, Bristol-Myers Squibb Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc, Novartis International AG, Pfizer Inc, Sanofi, and Teva Pharmaceutical Industries Ltd, NextPharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Broad-spectrum Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Broad-spectrum Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Broad-spectrum Antibiotics Market report?

Ans: The main players in the Broad-spectrum Antibiotics Market are Hanmi Cepha Plant, Globela Pharma, Allergan Plc, Bristol-Myers Squibb Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc, Novartis International AG, Pfizer Inc, Sanofi, and Teva Pharmaceutical Industries Ltd, NextPharma

What are the Application segmentation covered in the Broad-spectrum Antibiotics Market report?

Ans: The Applications covered in the Broad-spectrum Antibiotics Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Broad-spectrum Antibiotics Market report?

Ans: The Types covered in the Broad-spectrum Antibiotics Market report are Cephalosporins, Penicillins, Carbapenems, Tetracyclines, Chloramphenicol, Others

1 Broad-spectrum Antibiotics Market Overview

1.1 Product Definition

1.2 Broad-spectrum Antibiotics by Type

1.2.1 Global Broad-spectrum Antibiotics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Cephalosporins

1.2.3 Penicillins

1.2.4 Carbapenems

1.2.5 Tetracyclines

1.2.6 Chloramphenicol

1.2.7 Others

1.3 Broad-spectrum Antibiotics by Application

1.3.1 Global Broad-spectrum Antibiotics Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Pharmacy

1.4 Global Broad-spectrum Antibiotics Market Size Estimates and Forecasts

1.4.1 Global Broad-spectrum Antibiotics Revenue 2020-2031

1.4.2 Global Broad-spectrum Antibiotics Sales 2020-2031

1.4.3 Global Broad-spectrum Antibiotics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Broad-spectrum Antibiotics Market Competition by Manufacturers

2.1 Global Broad-spectrum Antibiotics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Broad-spectrum Antibiotics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Broad-spectrum Antibiotics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Broad-spectrum Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Broad-spectrum Antibiotics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Broad-spectrum Antibiotics, Product Type & Application

2.7 Global Key Manufacturers of Broad-spectrum Antibiotics, Date of Enter into This Industry

2.8 Global Broad-spectrum Antibiotics Market Competitive Situation and Trends

2.8.1 Global Broad-spectrum Antibiotics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Broad-spectrum Antibiotics Players Market Share by Revenue

2.8.3 Global Broad-spectrum Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Broad-spectrum Antibiotics Market Scenario by Region

3.1 Global Broad-spectrum Antibiotics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Broad-spectrum Antibiotics Sales by Region: 2020-2031

3.2.1 Global Broad-spectrum Antibiotics Sales by Region: 2020-2025

3.2.2 Global Broad-spectrum Antibiotics Sales by Region: 2026-2031

3.3 Global Broad-spectrum Antibiotics Revenue by Region: 2020-2031

3.3.1 Global Broad-spectrum Antibiotics Revenue by Region: 2020-2025

3.3.2 Global Broad-spectrum Antibiotics Revenue by Region: 2026-2031

3.4 North America Broad-spectrum Antibiotics Market Facts & Figures by Country

3.4.1 North America Broad-spectrum Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Broad-spectrum Antibiotics Sales by Country (2020-2031)

3.4.3 North America Broad-spectrum Antibiotics Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Broad-spectrum Antibiotics Market Facts & Figures by Country

3.5.1 Europe Broad-spectrum Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Broad-spectrum Antibiotics Sales by Country (2020-2031)

3.5.3 Europe Broad-spectrum Antibiotics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Broad-spectrum Antibiotics Market Facts & Figures by Region

3.6.1 Asia Pacific Broad-spectrum Antibiotics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Broad-spectrum Antibiotics Sales by Region (2020-2031)

3.6.3 Asia Pacific Broad-spectrum Antibiotics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Broad-spectrum Antibiotics Market Facts & Figures by Country

3.7.1 Latin America Broad-spectrum Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Broad-spectrum Antibiotics Sales by Country (2020-2031)

3.7.3 Latin America Broad-spectrum Antibiotics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Broad-spectrum Antibiotics Market Facts & Figures by Country

3.8.1 Middle East and Africa Broad-spectrum Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Broad-spectrum Antibiotics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Broad-spectrum Antibiotics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Broad-spectrum Antibiotics Sales by Type (2020-2031)

4.1.1 Global Broad-spectrum Antibiotics Sales by Type (2020-2025)

4.1.2 Global Broad-spectrum Antibiotics Sales by Type (2026-2031)

4.1.3 Global Broad-spectrum Antibiotics Sales Market Share by Type (2020-2031)

4.2 Global Broad-spectrum Antibiotics Revenue by Type (2020-2031)

4.2.1 Global Broad-spectrum Antibiotics Revenue by Type (2020-2025)

4.2.2 Global Broad-spectrum Antibiotics Revenue by Type (2026-2031)

4.2.3 Global Broad-spectrum Antibiotics Revenue Market Share by Type (2020-2031)

4.3 Global Broad-spectrum Antibiotics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Broad-spectrum Antibiotics Sales by Application (2020-2031)

5.1.1 Global Broad-spectrum Antibiotics Sales by Application (2020-2025)

5.1.2 Global Broad-spectrum Antibiotics Sales by Application (2026-2031)

5.1.3 Global Broad-spectrum Antibiotics Sales Market Share by Application (2020-2031)

5.2 Global Broad-spectrum Antibiotics Revenue by Application (2020-2031)

5.2.1 Global Broad-spectrum Antibiotics Revenue by Application (2020-2025)

5.2.2 Global Broad-spectrum Antibiotics Revenue by Application (2026-2031)

5.2.3 Global Broad-spectrum Antibiotics Revenue Market Share by Application (2020-2031)

5.3 Global Broad-spectrum Antibiotics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Hanmi Cepha Plant

6.1.1 Hanmi Cepha Plant Company Information

6.1.2 Hanmi Cepha Plant Description and Business Overview

6.1.3 Hanmi Cepha Plant Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Hanmi Cepha Plant Broad-spectrum Antibiotics Product Portfolio

6.1.5 Hanmi Cepha Plant Recent Developments/Updates

6.2 Globela Pharma

6.2.1 Globela Pharma Company Information

6.2.2 Globela Pharma Description and Business Overview

6.2.3 Globela Pharma Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Globela Pharma Broad-spectrum Antibiotics Product Portfolio

6.2.5 Globela Pharma Recent Developments/Updates

6.3 Allergan Plc

6.3.1 Allergan Plc Company Information

6.3.2 Allergan Plc Description and Business Overview

6.3.3 Allergan Plc Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Allergan Plc Broad-spectrum Antibiotics Product Portfolio

6.3.5 Allergan Plc Recent Developments/Updates

6.4 Bristol-Myers Squibb Company

6.4.1 Bristol-Myers Squibb Company Company Information

6.4.2 Bristol-Myers Squibb Company Description and Business Overview

6.4.3 Bristol-Myers Squibb Company Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bristol-Myers Squibb Company Broad-spectrum Antibiotics Product Portfolio

6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates

6.5 F.Hoffmann-La Roche Ltd.

6.5.1 F.Hoffmann-La Roche Ltd. Company Information

6.5.2 F.Hoffmann-La Roche Ltd. Description and Business Overview

6.5.3 F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Product Portfolio

6.5.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates

6.6 GlaxoSmithKline Plc

6.6.1 GlaxoSmithKline Plc Company Information

6.6.2 GlaxoSmithKline Plc Description and Business Overview

6.6.3 GlaxoSmithKline Plc Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline Plc Broad-spectrum Antibiotics Product Portfolio

6.6.5 GlaxoSmithKline Plc Recent Developments/Updates

6.7 Merck & Co. Inc

6.7.1 Merck & Co. Inc Company Information

6.7.2 Merck & Co. Inc Description and Business Overview

6.7.3 Merck & Co. Inc Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck & Co. Inc Broad-spectrum Antibiotics Product Portfolio

6.7.5 Merck & Co. Inc Recent Developments/Updates

6.8 Novartis International AG, Pfizer Inc

6.8.1 Novartis International AG, Pfizer Inc Company Information

6.8.2 Novartis International AG, Pfizer Inc Description and Business Overview

6.8.3 Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Product Portfolio

6.8.5 Novartis International AG, Pfizer Inc Recent Developments/Updates

6.9 Sanofi, and Teva Pharmaceutical Industries Ltd

6.9.1 Sanofi, and Teva Pharmaceutical Industries Ltd Company Information

6.9.2 Sanofi, and Teva Pharmaceutical Industries Ltd Description and Business Overview

6.9.3 Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Product Portfolio

6.9.5 Sanofi, and Teva Pharmaceutical Industries Ltd Recent Developments/Updates

6.10 NextPharma

6.10.1 NextPharma Company Information

6.10.2 NextPharma Description and Business Overview

6.10.3 NextPharma Broad-spectrum Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 NextPharma Broad-spectrum Antibiotics Product Portfolio

6.10.5 NextPharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Broad-spectrum Antibiotics Industry Chain Analysis

7.2 Broad-spectrum Antibiotics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Broad-spectrum Antibiotics Production Mode & Process Analysis

7.4 Broad-spectrum Antibiotics Sales and Marketing

7.4.1 Broad-spectrum Antibiotics Sales Channels

7.4.2 Broad-spectrum Antibiotics Distributors

7.5 Broad-spectrum Antibiotics Customer Analysis

8 Broad-spectrum Antibiotics Market Dynamics

8.1 Broad-spectrum Antibiotics Industry Trends

8.2 Broad-spectrum Antibiotics Market Drivers

8.3 Broad-spectrum Antibiotics Market Challenges

8.4 Broad-spectrum Antibiotics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Hanmi Cepha Plant

Globela Pharma

Allergan plc

Bristol Myers Squibb Company

F Hoffmann La Roche Ltd

GlaxoSmithKline PLC

Merck& Co. Inc

NextPharma

Novartis International AG, Pfizer Inc

Sanofi, and Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Global Broad-spectrum Antibiotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Broad-spectrum Antibiotics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Broad-spectrum Antibiotics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Broad-spectrum Antibiotics Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Broad-spectrum Antibiotics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Broad-spectrum Antibiotics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Broad-spectrum Antibiotics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Broad-spectrum Antibiotics Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Broad-spectrum Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Broad-spectrum Antibiotics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Broad-spectrum Antibiotics, Product Type & Application

Table 12. Global Key Manufacturers of Broad-spectrum Antibiotics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Broad-spectrum Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Broad-spectrum Antibiotics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Broad-spectrum Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Broad-spectrum Antibiotics Sales by Region (2020-2025) & (K Units)

Table 18. Global Broad-spectrum Antibiotics Sales Market Share by Region (2020-2025)

Table 19. Global Broad-spectrum Antibiotics Sales by Region (2026-2031) & (K Units)

Table 20. Global Broad-spectrum Antibiotics Sales Market Share by Region (2026-2031)

Table 21. Global Broad-spectrum Antibiotics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Broad-spectrum Antibiotics Revenue Market Share by Region (2020-2025)

Table 23. Global Broad-spectrum Antibiotics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Broad-spectrum Antibiotics Revenue Market Share by Region (2026-2031)

Table 25. North America Broad-spectrum Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Broad-spectrum Antibiotics Sales by Country (2020-2025) & (K Units)

Table 27. North America Broad-spectrum Antibiotics Sales by Country (2026-2031) & (K Units)

Table 28. North America Broad-spectrum Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Broad-spectrum Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Broad-spectrum Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Broad-spectrum Antibiotics Sales by Country (2020-2025) & (K Units)

Table 32. Europe Broad-spectrum Antibiotics Sales by Country (2026-2031) & (K Units)

Table 33. Europe Broad-spectrum Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Broad-spectrum Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Broad-spectrum Antibiotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Broad-spectrum Antibiotics Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Broad-spectrum Antibiotics Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Broad-spectrum Antibiotics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Broad-spectrum Antibiotics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Broad-spectrum Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Broad-spectrum Antibiotics Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Broad-spectrum Antibiotics Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Broad-spectrum Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Broad-spectrum Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Broad-spectrum Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Broad-spectrum Antibiotics Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Broad-spectrum Antibiotics Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Broad-spectrum Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Broad-spectrum Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Broad-spectrum Antibiotics Sales (K Units) by Type (2020-2025)

Table 51. Global Broad-spectrum Antibiotics Sales (K Units) by Type (2026-2031)

Table 52. Global Broad-spectrum Antibiotics Sales Market Share by Type (2020-2025)

Table 53. Global Broad-spectrum Antibiotics Sales Market Share by Type (2026-2031)

Table 54. Global Broad-spectrum Antibiotics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Broad-spectrum Antibiotics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Broad-spectrum Antibiotics Revenue Market Share by Type (2020-2025)

Table 57. Global Broad-spectrum Antibiotics Revenue Market Share by Type (2026-2031)

Table 58. Global Broad-spectrum Antibiotics Price (US$/Unit) by Type (2020-2025)

Table 59. Global Broad-spectrum Antibiotics Price (US$/Unit) by Type (2026-2031)

Table 60. Global Broad-spectrum Antibiotics Sales (K Units) by Application (2020-2025)

Table 61. Global Broad-spectrum Antibiotics Sales (K Units) by Application (2026-2031)

Table 62. Global Broad-spectrum Antibiotics Sales Market Share by Application (2020-2025)

Table 63. Global Broad-spectrum Antibiotics Sales Market Share by Application (2026-2031)

Table 64. Global Broad-spectrum Antibiotics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Broad-spectrum Antibiotics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Broad-spectrum Antibiotics Revenue Market Share by Application (2020-2025)

Table 67. Global Broad-spectrum Antibiotics Revenue Market Share by Application (2026-2031)

Table 68. Global Broad-spectrum Antibiotics Price (US$/Unit) by Application (2020-2025)

Table 69. Global Broad-spectrum Antibiotics Price (US$/Unit) by Application (2026-2031)

Table 70. Hanmi Cepha Plant Company Information

Table 71. Hanmi Cepha Plant Description and Business Overview

Table 72. Hanmi Cepha Plant Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Hanmi Cepha Plant Broad-spectrum Antibiotics Product

Table 74. Hanmi Cepha Plant Recent Developments/Updates

Table 75. Globela Pharma Company Information

Table 76. Globela Pharma Description and Business Overview

Table 77. Globela Pharma Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Globela Pharma Broad-spectrum Antibiotics Product

Table 79. Globela Pharma Recent Developments/Updates

Table 80. Allergan Plc Company Information

Table 81. Allergan Plc Description and Business Overview

Table 82. Allergan Plc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Allergan Plc Broad-spectrum Antibiotics Product

Table 84. Allergan Plc Recent Developments/Updates

Table 85. Bristol-Myers Squibb Company Company Information

Table 86. Bristol-Myers Squibb Company Description and Business Overview

Table 87. Bristol-Myers Squibb Company Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Bristol-Myers Squibb Company Broad-spectrum Antibiotics Product

Table 89. Bristol-Myers Squibb Company Recent Developments/Updates

Table 90. F.Hoffmann-La Roche Ltd. Company Information

Table 91. F.Hoffmann-La Roche Ltd. Description and Business Overview

Table 92. F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Product

Table 94. F.Hoffmann-La Roche Ltd. Recent Developments/Updates

Table 95. GlaxoSmithKline Plc Company Information

Table 96. GlaxoSmithKline Plc Description and Business Overview

Table 97. GlaxoSmithKline Plc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline Plc Broad-spectrum Antibiotics Product

Table 99. GlaxoSmithKline Plc Recent Developments/Updates

Table 100. Merck & Co. Inc Company Information

Table 101. Merck & Co. Inc Description and Business Overview

Table 102. Merck & Co. Inc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Merck & Co. Inc Broad-spectrum Antibiotics Product

Table 104. Merck & Co. Inc Recent Developments/Updates

Table 105. Novartis International AG, Pfizer Inc Company Information

Table 106. Novartis International AG, Pfizer Inc Description and Business Overview

Table 107. Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Product

Table 109. Novartis International AG, Pfizer Inc Recent Developments/Updates

Table 110. Sanofi, and Teva Pharmaceutical Industries Ltd Company Information

Table 111. Sanofi, and Teva Pharmaceutical Industries Ltd Description and Business Overview

Table 112. Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Product

Table 114. Sanofi, and Teva Pharmaceutical Industries Ltd Recent Developments/Updates

Table 115. NextPharma Company Information

Table 116. NextPharma Description and Business Overview

Table 117. NextPharma Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. NextPharma Broad-spectrum Antibiotics Product

Table 119. NextPharma Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Broad-spectrum Antibiotics Distributors List

Table 123. Broad-spectrum Antibiotics Customers List

Table 124. Broad-spectrum Antibiotics Market Trends

Table 125. Broad-spectrum Antibiotics Market Drivers

Table 126. Broad-spectrum Antibiotics Market Challenges

Table 127. Broad-spectrum Antibiotics Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Broad-spectrum Antibiotics

Figure 2. Global Broad-spectrum Antibiotics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Broad-spectrum Antibiotics Market Share by Type: 2024 & 2031

Figure 4. Cephalosporins Product Picture

Figure 5. Penicillins Product Picture

Figure 6. Carbapenems Product Picture

Figure 7. Tetracyclines Product Picture

Figure 8. Chloramphenicol Product Picture

Figure 9. Others Product Picture

Figure 10. Global Broad-spectrum Antibiotics Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Broad-spectrum Antibiotics Market Share by Application: 2024 & 2031

Figure 12. Hospital

Figure 13. Pharmacy

Figure 14. Global Broad-spectrum Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Broad-spectrum Antibiotics Market Size (2020-2031) & (US$ Million)

Figure 16. Global Broad-spectrum Antibiotics Sales (2020-2031) & (K Units)

Figure 17. Global Broad-spectrum Antibiotics Average Price (US$/Unit) & (2020-2031)

Figure 18. Broad-spectrum Antibiotics Report Years Considered

Figure 19. Broad-spectrum Antibiotics Sales Share by Manufacturers in 2024

Figure 20. Global Broad-spectrum Antibiotics Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Broad-spectrum Antibiotics Players: Market Share by Revenue in Broad-spectrum Antibiotics in 2024

Figure 22. Broad-spectrum Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Broad-spectrum Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Broad-spectrum Antibiotics Sales Market Share by Country (2020-2031)

Figure 25. North America Broad-spectrum Antibiotics Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Broad-spectrum Antibiotics Sales Market Share by Country (2020-2031)

Figure 29. Europe Broad-spectrum Antibiotics Revenue Market Share by Country (2020-2031)

Figure 30. Germany Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Broad-spectrum Antibiotics Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Broad-spectrum Antibiotics Revenue Market Share by Region (2020-2031)

Figure 37. China Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Broad-spectrum Antibiotics Sales Market Share by Country (2020-2031)

Figure 48. Latin America Broad-spectrum Antibiotics Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Broad-spectrum Antibiotics Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Broad-spectrum Antibiotics Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Broad-spectrum Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Broad-spectrum Antibiotics by Type (2020-2031)

Figure 58. Global Revenue Market Share of Broad-spectrum Antibiotics by Type (2020-2031)

Figure 59. Global Broad-spectrum Antibiotics Price (US$/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Broad-spectrum Antibiotics by Application (2020-2031)

Figure 61. Global Revenue Market Share of Broad-spectrum Antibiotics by Application (2020-2031)

Figure 62. Global Broad-spectrum Antibiotics Price (US$/Unit) by Application (2020-2031)

Figure 63. Broad-spectrum Antibiotics Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions